SGLT2 inhibitors lower blood sugar by a novel insulin-independent
mechanism:
- Blocking sodium-glucose cotransporter-2 in the proximal renal tubules
- Promoting urinaryglucose excretion
- Leading to modest weight loss, reduced BP, and improved metabolic balance